Amanda Littlewood‐Evans

Author

Also Known As

A Littlewood-Evans, A Littlewood‐Evans, A. Littlewood-Evans, Amanda J. Littlewood-Evans, Amanda Littlewood-Evans, Amanda Littlewood‐Evans

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research Novartis (United States)University of Liverpool

About

Amanda Littlewood‐Evans is an author at Novartis (Switzerland) specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.8K
2	Natural Sciences	2	2	74
3	Allergy	2	2	243
4	Biochemistry	2	2	117
5	Social Sciences	1	1	90

Amanda Littlewood‐Evans

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis Amanda Littlewood‐Evans, Sophie Sarret, Verena Apfel, The Journal of Experimental Medicine ImmunologyImmune RegulationInnate ImmunityImmune SystemExtracellular Succinate	2016	467
Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization Kenneth R. LaMontagne, Amanda Littlewood‐Evans, Christian Schnell, Cancer Research	2006	297
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor Heidi A. Lane, Jeanette M. Wood, Paul M.J. McSheehy, Clinical Cancer Research	2009	250
Small-molecule factor B inhibitor for the treatment of complement-mediated diseases Anna Schubart, Karen Anderson, Nello Mainolfi, Proceedings of the National Academy of Sciences ImmunologyBiological TherapyDermatologyImmunotherapyInflammation	2019	206
TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis Joschka Willemsen, Marie‐Therese Neuhoff, Thomas Hoyler, Cell Reports ImmunologyPathologyCgas/sting-dependent Interferon ResponsesInflammatory ArthritisInflammation	2021	197
Localization of cathepsin K in human osteoclasts by in situ hybridization and immunohistochemistry Amanda Littlewood‐Evans, Toshio Kokubo, Osamu Ishibashi, Bone Bone Morphogenic ProteinMedicineHuman OsteoclastsOsteoarthritisBone Metabolism	1997	191
Effects of the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 on the Tumor Vasculature: Implications for Clinical Imaging Christian Schnell, Frédéric Stauffer, Peter R. Allegrini, Cancer Research ImmunologyCancer BiologyTumor BiologyAngiogenesisReceptor Tyrosine Kinase	2008	174
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase Daniela Angst, F. Gessier, Philipp Janser, Journal of Medicinal Chemistry	2020	149
Mural Cell Associated VEGF Is Required for Organotypic Vessel Formation Lasse Evensen, David Micklem, Anna Blois, PLoS ONE	2009	146
Th17 Cells, Not IL-17+ γδ T Cells, Drive Arthritic Bone Destruction in Mice and Humans Bernadette Pöllinger, Tobias Junt, Barbara Metzler, The Journal of Immunology	2011	123

Page 1